推荐产品
用途
sufficient for 100 colorimetric or fluorometric tests
检测方法
colorimetric
fluorometric
相关疾病
gastrointestinal diseases
运输
wet ice
储存温度
−20°C
基因信息
human ... GPT(2875)
mouse ... GPT(76282)
rat ... GPT(81670)
一般描述
丙氨酸氨基转移酶（ALT），也称为血清谷氨酸-丙酮酸转氨酶（SGPT），是一种吡哆醛-磷酸盐依赖型的酶，其可催化氨基从丙氨酸到α-酮戊二酸的可逆型转移，并生成丙酮酸和谷氨酸。ALT主要在肝脏和血清中被发现，但也存在于其他组织中。肝细胞损伤经常会导致血清ALT水平的升高而血清ALT水平可被用作肝损伤的一种标志物。
应用
ALT活性检测试剂盒已用于确定血清样品中丙氨酸氨基转移酶（ALT）的活性。
特点和优势
兼容高通量处理系统。
适用性
适于测定组织、细胞和血清等生物学样品中的丙氨酸转氨酶（ALT）活性。
原理
ALT活性检测试剂盒可提供在多种生物学样本进行简单而直接的ALT活性测定过程。
ALT活性由一种偶联酶检测所确定，其可产生与生成的丙酮酸盐成比例的比色（570 nm）/荧光（λex = 535/λem = 587 nm）产物。一个单位的ALT定义为在 37 °C每分钟可生成1.0 μ摩尔丙酮酸所需的酶量。
ALT活性由一种偶联酶检测所确定，其可产生与生成的丙酮酸盐成比例的比色（570 nm）/荧光（λex = 535/λem = 587 nm）产物。一个单位的ALT定义为在 37 °C每分钟可生成1.0 μ摩尔丙酮酸所需的酶量。
警示用语：
Danger
危险声明
危险分类
Aquatic Chronic 3 - Resp. Sens. 1 - Skin Sens. 1
储存分类代码
10 - Combustible liquids
WGK
WGK 3
法规信息
常规特殊物品
从最新的版本中选择一种：
分析证书(COA)
Lot/Batch Number
Investigation of Therapeutic Effects of $\alpha$-Mangostin on Thioacetamide-Induced Cirrhosis in Rats
Nilbunga S.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, 98(9), S91-S97 (2015)
Brett Palaschak et al.
Molecular therapy. Methods & clinical development, 5, 142-152 (2017-05-10)
Multiple independent adeno-associated virus (AAV) gene therapy clinical trials for hemophilia B, utilizing different AAV serotypes, have reported a vector dose-dependent loss of circulating factor IX (FIX) protein associated with capsid-specific CD8
Nan Wu et al.
Laboratory investigation; a journal of technical methods and pathology, 97(7), 843-853 (2017-06-06)
The Hippo signaling pathway and the Notch signaling pathway are evolutionary conserved signaling cascades that have important roles in embryonic development of many organs. In murine liver, disruption of either pathway impairs intrahepatic bile duct development. Recent studies suggested that
Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-KB activity.
Kuang H, et al.
Oncology Reports, 35(1), 307-317 (2016)
L Bočkor et al.
Gene therapy, 24(10), 649-660 (2017-08-15)
Adeno-associated virus (AAV) -mediated gene therapy is a promising strategy to treat liver-based monogenic diseases. However, two major obstacles limit its success: first, vector dilution in actively dividing cells, such as hepatocytes in neonates/children, due to the non-integrating nature of
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门